These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21549569)

  • 1. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparasitic therapy.
    Kappagoda S; Singh U; Blackburn BG
    Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.
    Witschel M; Rottmann M; Kaiser M; Brun R
    PLoS Negl Trop Dis; 2012; 6(10):e1805. PubMed ID: 23145187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 7. Alkaloids with antiprotozoal activity.
    Osorio EJ; Robledo SM; Bastida J
    Alkaloids Chem Biol; 2008; 66():113-90. PubMed ID: 19025098
    [No Abstract]   [Full Text] [Related]  

  • 8. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
    Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
    Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
    PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K
    Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
    Cardona-G W; Yepes AF; Herrera-R A
    Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
    Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
    Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and molecular mechanisms of drug resistance in parasites.
    Ouellette M
    Trop Med Int Health; 2001 Nov; 6(11):874-82. PubMed ID: 11703841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the major imported protozoan infections in travelers and migrants.
    Norman FF; Comeche B; Chamorro S; Pérez-Molina JA; López-Vélez R
    Future Microbiol; 2020 Feb; 15():213-225. PubMed ID: 32065535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron-based drugs as antiprotozoals.
    Jacobs RT; Plattner JJ; Keenan M
    Curr Opin Infect Dis; 2011 Dec; 24(6):586-92. PubMed ID: 22001943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.